Who We Are

  • Akers Nanotechnology is a leading global rapid diagnostic test developer and supplier and vaccine wholesaler.
  • Our company works with agents and suppliers all over the world. The current business situation has been delicate and chaotic since the global COVID-19 pandemic. Trade between factories and customers is difficult because of the resurgence of “brokers” who want to appropriate a large market without knowledge or know-how. This new global demand is extremely large and supply chains are difficult to manage in the face of this growing need. We prefer to surround ourselves with known and recognized companies with which we already work.

Dr. Raymond F. Akers, Jr., Ph.D.

Founder and CEO of Akers

Dr. Raymond F. Akers Jr. has spent the past 35 years as an innovator in rapid diagnostic test products, and as a supplier of pharmaceuticals and vaccines. He invented the company’s products, and holds numerous patents and regulatory approvals. Dr. Akers has taken two of his companies public in the IPO process, one on the NASDAQ and one on the London Stock Exchange’s Alternative Investment Market, and has successfully closed numerous secondary offerings. He holds a doctorate in Neuroscience from Northwestern University and a B.A. in Biology from Saint Joseph’s University.

Our Team is Here to Help You

Raymond F. Akers Jr., Ph.D.

CEO Akers Nanotechnology USA WFC Medical Worldwide Manager

Guy Hazout

CEO Civilia SAS France WFC worldwide Sales Manager

Susan Andrelczyk

General Manager,
Regulatory And Certificates

Philippe Brisset

Legal council WFC Akers Civilia group

Ethan Levy

General Manager,
Middle East region

Philippe Brisset

Legal council WFC Akers Civilia group

Ethan Levy

General Manager,
Middle East region

WELCOME TO WFC STRATEGY

 

WHO WE ARE

 

IMMUNITY TO COVID-19 TEST

 

APP WFC

 

URINE TEST KIT ANTIBODY

 

BLOOD TEST – 2 IN 1

 

CERTIFICATIONS

 

CONTACT

 

PRESS